Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Patrick E.McDaniel who wrote (5944)	1/26/1999 4:19:00 PM
From: Joe E.	Read Replies (1) of 6136

From press release; "Under the terms of the agreement, which is valued at approximately $2.1 billion, each share of Agouron stock will be exchanged for approximately $60 worth of Warner-Lambert stock within a range of .8108 to .93 shares of Warner-Lambert common stock for each share of Agouron common stock. The exact exchange rate will be based on the average price of Warner-Lambert stock prior to closing" marketwatch.newsalert.com WLA closed about 69 today

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next